2-(phosphonooxy)prop-2-enoic acid

Compound number
MolPort-002-523-981
CAS number
138-08-9; 73-89-2
IUPAC
2-(phosphonooxy)prop-2-enoic acid
IUPAC traditional
phosphoenolpyruvic acid
SMILES
OC(=O)C(=C)OP(O)(O)=O
InChI key
DTBNBXWJWCWCIK-UHFFFAOYSA-N
Molecular formula
Molecular weight
168.041
DMSO Solubility
Not known

Marketplace Offers

INTERBIOSCREEN DOO BAR

Direct S&H to USA:
220.00 USD
Catalog
Screening compound
Ships out
15 business days
Purity
92 - 98%
Last updated
last month
In warehouse
10.00 mg

Supplier Catalogue Data

Pack size Ships out Price Quantity
3 micromol October 25, 2022 84.60 USD
Add to Cart Buy
5 micromol October 25, 2022 135.00 USD
Add to Cart Buy
10 micromol October 25, 2022 218.70 USD
Add to Cart Buy

MedChemExpress (made-to-order)

Direct S&H to USA:
50.00 USD
Catalog
Building blocks
Ships out
20 business days
Purity
>98%
Last updated
this month
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 g November 1, 2022 166.10 USD
Add to Cart Buy
5 g November 1, 2022 484.00 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-002-523-981
CAS number
138-08-9; 73-89-2

Names, Synonyms and 3rd Party Identifiers

Name
2-(phosphonooxy)acrylate
2-(phosphonooxy)acrylic acid
2-dihydroxyphosphinoyloxyacrylic acid
Phosphoenolpyruvate
Phosphoenolpyruvic acid
MFCD00039109

InChI

InChI
1/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)
InChI key
DTBNBXWJWCWCIK-UHFFFAOYSA-N

Formula

Molecular formula
C3H5O6P
Molecular weight
168.041

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback